FDA Investigator Freddy Ortiz Colon

Freddy Ortiz Colon has inspections in 5 countries as of 23 Jun 2023. Freddy Ortiz Colon has collaborated with a combinined 1527 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

23 Jun 2023

Investigator Role:

FDA Investigator

Redica ID:

100001307

Country:

India, Switzerland, Finland, Belgium, France

Co-Investigator(s):

Ademola O Daramola, Akbar J Zaidi, Ann Marie Montemurro, Ann Marie Schofield, Anna Lazar, Atul J Agrawal, Azza Talaat, Azzu Talaat, Bryan A Galvez, Burnell M Henry, CDR Jeremy L Wally, PhD, Christian D Lynch (CDL), Claire M Minden, Cynthia J Lee, MS, Cynthia Jim, CSO, Daniel J Roberts, Darren S Brown, David A Oluwo, Dipesh K Shah, Doan T Nguyen, PharmD, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Eileen A Liu, Emmanuel J Ramos, Eric M Mueller, PharmD, Farhana Khan, Felix Maldonado, Freddy Ortiz, Gam S Zamil, Gwyn G Dickinson, Jacqueline Mdiaz Albertini, Jawaid Hamid, Jay T Wong, Jeffery A Hangartner, Jennifer L Gustavus, Jogy George, Jose Acruz Gonzalez, Jose E Melendez, DDC, June P Page, Justin A Boyd, Kent C Faul, Kham Phommachanh, Kim Lthomas Cruse, Kristen D Evans, Larry K Hampton, Lisa B Orr, Lisa Shin, Marie Bbuen Bigornia, Marvin D Jones, Matthew B Casale, Michael L Chasey, Michael R Goga, Michele Perry Williams, Miguel A Martinez, Mihaly S Ligmond, Mizanne E Lewis, Mra B Kamberem, Nebil A Oumer, Nicholas L Paulin, Omotunde O Osunsanmi, Pankaj H Amin, Paula A Trost, Peter E Baker, Prabhu P Raju, Randa Melhem, PhD, Rose M Ashley, Saleem A Akhtar, Sanket N Patel, Scott T Ballard, Sherry G Bous, Simone E Pitts, Stephen D Eich, Steven M Weinman, Taichun Qin, PhD, Tamil Arasu, PhD, Terri L Dodds, Thomas J Arista, Timothy T Kapsala, Tomika L Bivens, Toyin B Oladimeji, Unnee Ranjan, Veronica Fuentes, MS, Virgilio F Pacio, CSO, Walden H Lee, Yasamin Ameri, Yonggang Wang, PhD, Yumi J Hiramine, Yvins Dezan

Freddy Ortiz Colon's Documents

Publish Date	Document Type	Title
April, 2023	FDA 483	Similasan AG - Form 483, 2023-04-04
June, 2013	FDA 483	Baxalta Belgium Manufacturing SA - Form 483, 2013-06-18
March, 2015	FDA 483	Fresenius Kabi Oncology Limited - Form 483, 2015-03-03
June, 2013	EIR	Baxalta Belgium Manufacturing SA - EIR, 2013-06-18
November, 2019	FDA 483	Eugia Pharma Specialities Limited - Form 483, 2019-11-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more